NEW YORK–(BUSINESS WIRE)–Columbia Care Inc. (NEO: CCHW) (CSE: CCHW) (OTCQX: CCHWF) (FSE: 3LP) (“Columbia Care” or the “Company”) today announced that it will be reporting its first quarter financial results ended on March 31, 2022 before US financial markets open on Monday, May 16, 2022. Following the release of financial results, management will host a conference call at 8:00 a.m. EST to discuss financial and operating results for the first quarter of 2022.
Conference call and webcast details
To access the live conference call by phone, please dial 1-844-283-2900 (US callers) or 1-213-217-9431 (international callers). A live audio webcast of the call will also be available on the Investor Relations section of the Company’s website at https://ir.col-care.com/ or at https://edge.media-server.com/mmc/p be /xsdeznnb.
A replay of the audio webcast will be available on the Investor Relations section of the Company’s website approximately 2 hours after the call closes and will be archived for 30 days.
Waiver of Shareholders Meeting to Approve Cresco Labs Transaction
In connection with the previously announced agreement with Cresco Labs Inc., Columbia Care plans to hold its special meeting of Columbia Care stockholders on or about June 14, 2022 to consider such a transaction. In connection with the meeting, Columbia Care has filed a petition with the Ontario Securities Commission (the “OSC”) for an order from the OSC exempting Columbia Care from the requirements of subsection 8.1(1) of Multilateral Instrument 61-101 – Protection of minority shareholders on special transactions to obtain minority approval of the transaction from the holders of each affected Columbia Care share class, voting separately as a class in each case. If the OSC issues the order set forth in the motion, the holders of Columbia Care common stock and pro rata voting stock will vote together as a single class for the purposes of such minority consent. There is no guarantee that such an exemption will be granted.
About ColumbiaCare
Columbia Care is one of the largest and most experienced growers, manufacturers and distributors of cannabis products and related services licensed in 18 US jurisdictions and the EU. Columbia Care operates 131 facilities, including 99 dispensaries and 32 cultivation and manufacturing facilities, including those under development. Columbia Care is one of the original state medical cannabis suppliers in the United States and now delivers industry-leading products and services to both the medical and adult markets. In 2021, the company launched Cannabist, its new retail brand, creating a national pharmacy network leveraging proprietary technology platforms. The company offers products that include flower, edibles, oils, and tablets, and manufactures popular brands such as Seed & Strain, Triple Seven, gLeaf, Classix, Press, Amber, and Platinum Label CBD. For more information about Columbia Care, visit www.col-care.com.
Comments are closed.